High SOJA score denotes best anti-H. pylori regimen

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 271, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Therapies for H. pylori infection: still no ideal regimen

By  

Inpharma, Vol. 1, Iss. 1360, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

High failure rates with H. pylori eradication therapies

By  

Inpharma, Vol. 1, Iss. 1317, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

FR145715, a novel histamine H 2 receptor antagonist, with specific anti-Helicobacter pylori activities

By Ishikawa H.   Ito H.   Higaki M.   Higaki M.   Matsumoto Y.   Kamimura T.   Katsura Y.   Tomishi T.   Inoue Y.   Takasugi H.   Tomoi M.   Krakowka S.   Yoshida K.  

European Journal of Pharmacology, Vol. 378, Iss. 3, 1999-08 ,pp. : 299-310

Elsevier

Access to resources Recommend Favorite

Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy

By Shirai Naohito   Sugimoto Mitsushige   Kodaira Chise   Nishino Masafumi   Ikuma Mutsuhiro   Kajimura Masayoshi   Ohashi Kyoichi   Ishizaki Takashi   Hishida Akira   Furuta Takahisa  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 8, 2007-08 ,pp. : 743-749

Springer Publishing Company

Access to resources Recommend Favorite